Evidence map›Paper›PMID 34003838›Full record

ArticlePloS one2021

Mapping Rora expression in resting and activated CD4+ T cells.

Liora Haim-Vilmovsky, Johan Henriksson, Jennifer A Walker, Zhichao Miao, Eviatar Natan, Gozde Kar, Simon Clare, Jillian L Barlow, Evelina Charidemou, Lira Mamanova and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Association Analysis of SNPs inAnimals : an open access journal from MDPI · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 1 country.

Liora Haim-VilmovskyEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Johan HenrikssonEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-7745-2844
Jennifer A WalkerMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Zhichao MiaoEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-5777-9815
Eviatar NatanEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Gozde KarEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Simon ClareWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Jillian L BarlowMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Evelina CharidemouDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Lira MamanovaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Xi ChenWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Valentina ProserpioEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0003-2071-4206
Jhuma PramanikWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Steven WoodhouseDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Anna V ProtasioWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Mirjana EfremovaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Julian L GriffinDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Matt BerrimanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-9581-0377
Gordon DouganWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Jasmin FisherMicrosoft Research, Cambridge, United Kingdom.
John C MarioniEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Andrew N J McKenzieMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Sarah A TeichmannEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-6294-6366
European Bioinformatics Institute · GBWellcome Sanger Institute · GBMRC Laboratory of Molecular Biology · GBUniversity of Cambridge · GBMicrosoft Research (United Kingdom) · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council MC_U105178805Medical Research Council MC_UP_A090_1006Medical Research Council MR/P011705/1Medical Research Council MR/P011705/2Medical Research Council U105178805Wellcome Trust 100963/Z/13/ZWellcome Trust 108437/Z/15/ZWellcome Trust WT206194
6 · The paper itself

Abstract

The transcription factor Rora has been shown to be important for the development of ILC2 and the regulation of ILC3, macrophages and Treg cells. Here we investigate the role of Rora across CD4+ T cells in general, but with an emphasis on Th2 cells, both in vitro as well as in the context of several in vivo type 2 infection models. We dissect the function of Rora using overexpression and a CD4-conditional Rora-knockout mouse, as well as a RORA-reporter mouse. We establish the importance of Rora in CD4+ T cells for controlling lung inflammation induced by Nippostrongylus brasiliensis infection, and have measured the effect on downstream genes using RNA-seq. Using a systematic stimulation screen of CD4+ T cells, coupled with RNA-seq, we identify upstream regulators of Rora, most importantly IL-33 and CCL7. Our data suggest that Rora is a negative regulator of the immune system, possibly through several downstream pathways, and is under control of the local microenvironment.

Indexed as

AnimalsAntigens, HelminthCD4-Positive T-LymphocytesCells, CulturedCytokinesDisease Models, AnimalFemaleGene Expression RegulationLymphocyte ActivationMacrophagesMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNippostrongylusNuclear Receptor Subfamily 1, Group F, Member 1Antigens, HelminthCytokinesNuclear Receptor Subfamily 1, Group F, Member 1Rora protein, mouse

Identifiers

PMID34003838
PMCPMC8130942
OpenAlexW3162918056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.